KR830006288A - 카바펜암과 카바펜-2-엠의 제조방법 - Google Patents

카바펜암과 카바펜-2-엠의 제조방법 Download PDF

Info

Publication number
KR830006288A
KR830006288A KR1019810001651A KR810001651A KR830006288A KR 830006288 A KR830006288 A KR 830006288A KR 1019810001651 A KR1019810001651 A KR 1019810001651A KR 810001651 A KR810001651 A KR 810001651A KR 830006288 A KR830006288 A KR 830006288A
Authority
KR
South Korea
Prior art keywords
hydrogen
carbafen
methyl
preparing
arm
Prior art date
Application number
KR1019810001651A
Other languages
English (en)
Other versions
KR840000722B1 (ko
Inventor
루이스 로재티 로버트
Original Assignee
에밀 안토니 아고스티니
화이자 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에밀 안토니 아고스티니, 화이자 인코포레이티드 filed Critical 에밀 안토니 아고스티니
Publication of KR830006288A publication Critical patent/KR830006288A/ko
Application granted granted Critical
Publication of KR840000722B1 publication Critical patent/KR840000722B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Saccharide Compounds (AREA)

Abstract

내용 없음

Description

카바펜암과 카바펜-2-엠의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 다음 일반식(I)의 화합물을 반응 불활성 용매중 -100°C내지 35°C의 온도에서 다음 일반식(II)의 화합물로 전위시키는 광촉매법
    상기 식에서
    R7은 수소, 일치환 또은 이치환된 아세트아미도(이때 카복시 및 아미노기는 통상제으로 보호된다), 5-메틸-3-페닐이속사졸-4-카복스아미도, 또는(R5는 수소, 아세틸, 벤질옥시카보닐 또는 p-니트로벤질옥시카보닐이며 R6는 수소 또는 (C1-C5)알킬이고 R12는 수소 또는 메틸이다)이며, R2는 수소 또는 메톡시인데, 단 R2가 메톡시일 때 R7은 2-펜옥시아세트아미도이며 R8은 통상의 카복시보호기이며 R9는 메틸, 아세톡시메틸, 메탈설포닐옥시, OR10또는 SR10(R10은 (C1-C3)알킬, 2-벤질옥시카보닐아미노에틸, 2-아세트아미도에틸 또는 2-(p-니트로벤질옥시카보닐아미노)에틸이다)이다.
    ※참고사항:최초출원 내용에 의하여 공개하는 것임.
KR1019810001651A 1980-05-14 1981-05-13 카바펜암과 카바펜-2-엠의 제조방법 KR840000722B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14960480A 1980-05-14 1980-05-14
US149604 1980-05-14
US06/232,156 US4348264A (en) 1980-05-14 1981-02-09 Photocatalyzed process for producing carbapenams and carbapen-2-ems
US232156 1981-02-09

Publications (2)

Publication Number Publication Date
KR830006288A true KR830006288A (ko) 1983-09-20
KR840000722B1 KR840000722B1 (ko) 1984-05-24

Family

ID=26846880

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810001651A KR840000722B1 (ko) 1980-05-14 1981-05-13 카바펜암과 카바펜-2-엠의 제조방법

Country Status (17)

Country Link
US (1) US4348264A (ko)
EP (1) EP0040494B1 (ko)
KR (1) KR840000722B1 (ko)
AR (1) AR227425A1 (ko)
AU (1) AU524882B2 (ko)
CA (1) CA1171415A (ko)
DE (1) DE3162245D1 (ko)
DK (1) DK169892B1 (ko)
ES (1) ES502204A0 (ko)
FI (1) FI72518C (ko)
IE (1) IE51268B1 (ko)
IL (1) IL62848A (ko)
NO (1) NO157143C (ko)
NZ (1) NZ197072A (ko)
PH (1) PH16363A (ko)
PT (1) PT73026B (ko)
YU (1) YU43031B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4429128A (en) 1981-02-09 1984-01-31 Pfizer Inc. Carbapenams and carbapen-2-ems and process therefor
EP0160876A1 (en) * 1984-04-23 1985-11-13 Merck & Co. Inc. 1-Hetero-6-/1-Hydroxyethyl/-2-SR8-1-carbadethiapen-2-EM-3-carboxylic acids
DK270685A (da) * 1984-06-29 1985-12-30 Hoffmann La Roche Carbapenemderivater
US4675186A (en) 1985-04-18 1987-06-23 Pfizer Inc. 6-(1-acyl-1-hydroxymethyl)penicillanic acid derivatives
US5395931A (en) * 1988-06-30 1995-03-07 Merck & Co., Inc. 6-amido-1-methyl-2-(substituted-thio)carbapenems
US5138050A (en) * 1988-06-30 1992-08-11 Merck & Co., Inc. 6-amido-1-methyl carbapenems
US5055463A (en) * 1989-02-02 1991-10-08 Merck & Co., Inc. Spirocyclic 6-amido carbapenems
JP2003525298A (ja) * 2000-02-28 2003-08-26 ニューバイオティックス インコーポレイテッド 抗−感染性ｅｃｔａｔｍ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592751A (en) * 1969-04-14 1971-07-13 Lilly Co Eli Penicillin sulfoxide conversion process
US4234596A (en) * 1976-11-19 1980-11-18 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
BE867227A (fr) 1977-10-31 1978-11-20 Merck & Co Inc Preparation de l'acide 6-(alpha-hydroxyethyl)-7-oxo-1-azabicyclo (3,2,0) hept-2-ene-carboxylique et derives a activite antibiotique
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
US4262010A (en) * 1979-12-03 1981-04-14 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acids

Also Published As

Publication number Publication date
PT73026A (en) 1981-06-01
ES8203373A1 (es) 1982-04-01
IE51268B1 (en) 1986-11-26
EP0040494A1 (en) 1981-11-25
NO157143C (no) 1988-01-27
DE3162245D1 (en) 1984-03-22
YU43031B (en) 1989-02-28
FI72518B (fi) 1987-02-27
ES502204A0 (es) 1982-04-01
AU524882B2 (en) 1982-10-07
PT73026B (en) 1983-02-08
KR840000722B1 (ko) 1984-05-24
NO811628L (no) 1981-11-16
FI72518C (fi) 1987-06-08
AR227425A1 (es) 1982-10-29
IL62848A (en) 1984-05-31
CA1171415A (en) 1984-07-24
DK169892B1 (da) 1995-03-27
NO157143B (no) 1987-10-19
EP0040494B1 (en) 1984-02-15
DK211381A (da) 1981-11-15
NZ197072A (en) 1983-12-16
AU7051381A (en) 1981-11-19
PH16363A (en) 1983-09-08
IL62848A0 (en) 1981-07-31
FI811471L (fi) 1981-11-15
YU122181A (en) 1983-06-30
IE811070L (en) 1981-11-14
US4348264A (en) 1982-09-07

Similar Documents

Publication Publication Date Title
KR870001193A (ko) β-락탐 항생물질의 제조방법
KR870001142A (ko) 페닐 에테르의 제법
KR850000406A (ko) 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법
KR850003402A (ko) 2-아미노-5-하이드록시-4-메틸 피리미딘 유도체의 제조방법
KR840006963A (ko) 4-아미노알킬-2(3h)-인돌론을 제조하는 방법
KR830001947A (ko) 화합물의 제조방법
KR870006039A (ko) 신규 티아졸 화합물, 그 제조방법 및 이 화합물을 함유하는 약학적 조성물
DE69524103T2 (de) Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
KR830006288A (ko) 카바펜암과 카바펜-2-엠의 제조방법
KR830007562A (ko) 퀴놀린 카르복실산 유도체의 제조방법
KR840005101A (ko) 2-퀴놀린유도체의 제조방법
ES8606381A1 (es) Un procedimiento para preparar un derivado de uridina.
KR840005715A (ko) 3-페녹시-1-아제티딘 카아복사마이드의 제조방법
KR840000530A (ko) 신규 벤조트리아졸의 제조방법
KR830006209A (ko) 페닐프로 파르길아민 유도체의 제조방법
KR900000378A (ko) 타이로신유도체 및 그 제조법
KR870004038A (ko) 제초제 화합물의 제조방법
KR840007564A (ko) 치환된 벤질사이클로알케닐우레아 유도체의 제조방법
KR880013929A (ko) 신규 5-메톡시 알킬 암노늄 테트라히드로푸란 및 테트라히드로티오펜
KR850006180A (ko) 디아미노피리딘의 제조방법
GB1477701A (en) Basically substituted nitroimidazole-methylene-aminoimidazoli dinones
GB1425295A (en) Alpha-aminoylidenephthalides and processes for their preparation
KR920002497A (ko) 스테롤 화합물
KR860008142A (ko) 피라졸리디늄 일리드의 제조방법
KR870002089A (ko) 아미디노 아졸의 제조방법